Trials / Withdrawn
WithdrawnNCT01029223
The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Bayside Health · Other Government
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effect of slowing heart rate upon both central and peripheral blood pressures using a medication called Ivabradine which slows heart rate without affecting heart contraction, and to compare the effects of ivabradine to a traditional blood pressure lowering medication called metoprolol (which is a beta-blocker).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ivabradine | |
| DRUG | metoprolol | |
| DRUG | placebo |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2009-12-09
- Last updated
- 2011-11-09
Source: ClinicalTrials.gov record NCT01029223. Inclusion in this directory is not an endorsement.